All studies
OphthalmologyPhase II Recruiting

Investigational Treatment for Moderate-to-Severe Dry Eye Disease

Evaluating the safety and symptom relief of an investigational eye drop applied twice daily in adults with moderate-to-severe dry eye disease.

Time commitment

12 weeks

Compensation

Up to $700

Site

PRIME Trials — Northbrook

Who may qualify

Adults 18–85 with moderate-to-severe dry eye disease not adequately managed with artificial tears.

Step 1 of 1

Enroll in this study

Answer a few quick questions below and a study coordinator will call you to confirm eligibility. It takes about a minute and there is no obligation.

Start Enrollment

Investigational Treatment for Moderate-to-Severe Dry Eye Disease

Step 1 of 4Takes ~1 minute

Enter your ZIP code so we can match you to the nearest site.

Prefer to talk now?

Call or text our team and we will walk you through this study.